ES2456267T3 - Medicamento con levadura - Google Patents

Medicamento con levadura Download PDF

Info

Publication number
ES2456267T3
ES2456267T3 ES08841666.4T ES08841666T ES2456267T3 ES 2456267 T3 ES2456267 T3 ES 2456267T3 ES 08841666 T ES08841666 T ES 08841666T ES 2456267 T3 ES2456267 T3 ES 2456267T3
Authority
ES
Spain
Prior art keywords
yeast
drug
medicament
group
medication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08841666.4T
Other languages
English (en)
Spanish (es)
Inventor
Bodo Asmussen
Christiane Schiller
Werner Weitschies
Gregor Garbacz
Mahmoud A. Omer-Adam
Stefan Nagel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40299087&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2456267(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2456267T3 publication Critical patent/ES2456267T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES08841666.4T 2007-09-01 2008-08-21 Medicamento con levadura Active ES2456267T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102007041588A DE102007041588A1 (de) 2007-09-01 2007-09-01 Arzneimittel mit Hefe
DE102007041588 2007-09-01
PCT/EP2008/006897 WO2009052888A2 (de) 2007-09-01 2008-08-21 Arzneimittel mit hefe

Publications (1)

Publication Number Publication Date
ES2456267T3 true ES2456267T3 (es) 2014-04-21

Family

ID=40299087

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08841666.4T Active ES2456267T3 (es) 2007-09-01 2008-08-21 Medicamento con levadura

Country Status (14)

Country Link
US (1) US20120027856A1 (https=)
EP (1) EP2180885B1 (https=)
JP (1) JP2010536903A (https=)
KR (1) KR101259673B1 (https=)
CN (1) CN101795676B (https=)
AU (1) AU2008316051A1 (https=)
CA (1) CA2698327C (https=)
DE (1) DE102007041588A1 (https=)
ES (1) ES2456267T3 (https=)
MX (1) MX2010002167A (https=)
NZ (1) NZ584233A (https=)
RU (1) RU2452473C2 (https=)
WO (1) WO2009052888A2 (https=)
ZA (1) ZA201000853B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009027938A1 (de) * 2009-07-22 2011-01-27 Universität Greifswald Orales therapeutisches System und seine Verwendung
TW201403459A (zh) * 2012-04-20 2014-01-16 Enmotus Inc 具有資料管理機制之儲存系統及操作該儲存系統之方法
JP6456377B2 (ja) * 2014-06-10 2019-01-23 ライオン株式会社 清酒酵母を含有する錠剤
US11291683B2 (en) * 2016-04-01 2022-04-05 Access Business Group International Llc Bilayer tablets of B vitamins and process for preparing the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675174A (en) * 1985-08-16 1987-06-23 Alza Corporation Veterinary dispenser delivering beneficial agent by gas power generated in situ
WO1991004757A1 (en) 1989-10-02 1991-04-18 Cima Labs, Inc. Effervescent dosage form and method of administering same
EP1183014B1 (en) * 1999-06-14 2003-10-08 Cosmo S.p.A. Controlled release and taste masking oral pharmaceutical compositions
DE10120092B4 (de) * 2001-04-25 2008-03-20 Lts Lohmann Therapie-Systeme Ag Magensaftresistente Vorrichtung zur Freisetzung von mukoadhäsiven Wirkstoffträgern und Verfahren zur Herstellung der magensaftresistenten Vorrichtung
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
WO2002102415A1 (en) * 2001-06-18 2002-12-27 Blue Cross Laboratories Limited Gastric floating system
AU2002310470A1 (en) 2001-06-20 2003-01-08 Nina Nupponen Use of ribonuclease l in diagnosis of cancer
DE10224607B4 (de) * 2002-06-04 2008-03-13 Lts Lohmann Therapie-Systeme Ag Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung
EP1560569A4 (en) * 2002-10-11 2006-03-22 Depomed Dev Ltd GASTRORETENTIVE LEVODOPA DELIVERY FORM
US6835397B2 (en) * 2002-12-23 2004-12-28 Balchem Corporation Controlled release encapsulated bioactive substances
US20060003003A1 (en) 2004-06-28 2006-01-05 Bakker Johan A Oral sustained release formulation of tedisamil with gastric retention properties
DE102004042139B4 (de) 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US7799328B2 (en) * 2004-12-23 2010-09-21 Biocodex Method for treating weight loss in patients suffering from inflammatory bowel diseases
AU2008273095A1 (en) * 2007-07-12 2009-01-15 Dsm Ip Assets B.V. Nitrate reduction by a probiotic in the presence of a heme

Also Published As

Publication number Publication date
EP2180885B1 (de) 2014-01-29
KR101259673B1 (ko) 2013-05-06
WO2009052888A3 (de) 2009-10-15
RU2010109523A (ru) 2011-10-20
AU2008316051A1 (en) 2009-04-30
WO2009052888A2 (de) 2009-04-30
EP2180885A2 (de) 2010-05-05
US20120027856A1 (en) 2012-02-02
KR20100059880A (ko) 2010-06-04
CN101795676A (zh) 2010-08-04
CA2698327C (en) 2013-04-30
RU2452473C2 (ru) 2012-06-10
NZ584233A (en) 2012-02-24
ZA201000853B (en) 2010-10-27
JP2010536903A (ja) 2010-12-02
MX2010002167A (es) 2010-04-29
CN101795676B (zh) 2012-11-28
CA2698327A1 (en) 2009-04-30
DE102007041588A1 (de) 2009-03-05

Similar Documents

Publication Publication Date Title
Gupta et al. Osmotically controlled drug delivery system with associated drugs
CN111405895B (zh) 一种控释药物组合物及其制备方法
AU604825B2 (en) Therapeutic system for sparingly soluble active ingredients
CA2851765C (en) A gastroretentive dosage system and process of preparation thereof
WO2010020098A1 (zh) 胃滞留药物释出系统及其制备方法和用途
ES2456267T3 (es) Medicamento con levadura
ES2236012T3 (es) Medicacion antiviral.
CA2020802A1 (en) Solid dosage form for pharmaceutically active drugs
CN101695575A (zh) 含有他汀类降脂药物、双胍类降糖药物和烟酸的药物组合物
CN101732275A (zh) 一种单硝酸异山梨酯双层渗透泵控释片及其制备方法
Kumar et al. A comprehensive review on gastro retentive drug delivery system
CN105055360A (zh) 一种盐酸哌唑嗪控释片及其制备方法
CN111494328A (zh) 一种含阿卡波糖和达格列净的渗透泵片及其制备方法
Vani et al. A review on osmotic drug delivery system
Soni et al. Updates on approaches to increase the residence time of drug in the stomach for site specific delivery: Brief review
US7985427B2 (en) Gastric juice-resistant device for releasing mucoadhesive active substance excipients, and method for producing this gastric juice-resistant device
US20100143472A1 (en) Osmotic form for controlled release of active principles
CN101869711A (zh) 含有利尿剂类降血压药物和双胍类降糖药物的药物组合物及其用途
CN107865828B (zh) 防治结肠癌转移的口服结肠定位制剂、制备方法及其应用
Supe et al. OSMOTIC CONTROLLED DRUG DELIVERY SYSTEM: A NOVEL APPROACH FOR DIABETIC CARE
CN112294777B (zh) 一种盐酸伊伐布雷定缓释制剂及其制备方法和应用
WO2013051036A1 (en) Use of pharmaceutical composition for gastroretentive sustained and pulsatile drug delivery system
US20170172928A1 (en) Pharmaceutical system for oral delivery of sensitive therapeutic substances
Halba et al. Study on osmotic drug delivery system
HK40031748B (en) Controlled-release pharmaceutical composition and preparation method therefor